When building life sciences and pharmaceutical facilities, selecting the right construction consultant is critical. These projects demand strict compliance with regulations, precision in design, and expertise in managing complex systems like cleanrooms and HVAC. Delays or errors can lead to contamination, regulatory issues, or costly setbacks. This article highlights six leading U.S.-based firms known for their work on projects exceeding $50 million:
Each firm brings unique strengths in regulatory compliance, CQV integration, and delivery models like design-build or EPCM. Matching the right consultant to your project type - whether greenfield, retrofit, or advanced therapy - ensures smoother execution and minimizes risks.
Top Construction Consultants for Life Sciences & Pharma: Side-by-Side Comparison
In the world of life sciences construction, consulting firms play a pivotal role from the very beginning. They ensure that every aspect of design, procurement, and construction aligns with the strict regulatory standards of the industry. This responsibility becomes even more critical for projects exceeding $50 million, where the stakes are high. A misstep could lead to FDA audit failures, expensive rework, and delays that could jeopardize critical market opportunities. To find a consultant who can meet these demands, you’ll need to focus on several core factors.
So, what sets a great consulting firm apart? First and foremost, regulatory expertise is non-negotiable. The firm must demonstrate in-depth knowledge of regulations like FDA 21 CFR Parts 210/211, ISO 14644, and EU Annex 1. This expertise should be woven into every phase of the project - design, documentation, and execution - to avoid costly surprises late in the process.
Another key factor is CQV integration - the seamless incorporation of Commissioning, Qualification, and Validation from the design stage onward. As Salas O’Brien emphasizes:
"When commissioning, qualification, and validation are left to the final stretch of a project, even small gaps can cascade into production delays, rework, and regulatory exposure." [8]
Then there’s MEP complexity, which cannot be overlooked. For laboratory facilities, mechanical, electrical, and plumbing (MEP) systems often account for 40% to 60% of total construction costs [7]. Cleanroom HVAC systems alone are a significant expense, with recirculation air and chilled water systems each making up about 31% of cleanroom HVAC budgets [2]. A consultant without in-house expertise in areas like 100% outside air systems, pressure cascades, and HEPA filtration may struggle to control these critical cost drivers effectively.
Finally, consider their delivery model and speed. Design-build methods can accelerate timelines by 15% to 30% compared to traditional approaches [7], and some proprietary fast-track solutions boast reductions of up to 50% in time-to-production [4].
Here’s a quick framework to help you evaluate potential consultants:
| Evaluation Criterion | What To Look For |
|---|---|
| Regulatory Experience | Proven track record with FDA 21 CFR Parts 210/211, ISO 14644, and EU Annex 1 compliance |
| CQV Integration | CQV protocols developed in tandem with the design process |
| MEP Expertise | In-house engineers specializing in HVAC, pressure cascades, HEPA filtration, and process utilities |
| Fast-Track Capability | Use of design-build or EPCM models and early procurement of long-lead equipment |
| Modality Experience | Experience with CGT, ADCs, fill-finish, or aseptic suite projects |
| Digital Tools | Utilization of BIM, CFD modeling, and digital twins for better design decisions |
| Prefabrication Strategy | Off-site fabrication of MEP systems to minimize site congestion and rework |
Turner & Townsend brings precision and scale to life sciences construction, leveraging a global network of over 1,000 specialists who combine in-depth industry knowledge with insights into key U.S. markets like Boston and San Diego [10].
Their approach, called "joined-up delivery", is all about integration. Instead of treating planning, procurement, and construction as separate steps, they manage these as one seamless program. This method is especially valuable for projects that demand cGMP compliance or involve advanced therapies like genomics and biologics manufacturing. By combining strategy, commercial discipline, and hands-on execution from the outset, Turner & Townsend ensures a streamlined process for even the most complex builds.
"The challenge is balancing the need for speed with the absolute rigour of a regulated environment. Facilities need to be ready to perform from day one and also resilient enough to evolve as science advances." - Turner & Townsend [10]
Their project portfolio showcases a wide range of expertise. For example, they are supporting Moderna's vaccine manufacturing facility in Quebec and have completed Brazil's first advanced pathogen research laboratory at CNPEM [10]. They also led the delivery of ONE BioHub in Aberdeen, UK, where their ability to maintain the project’s original vision from concept to completion earned high praise from the client [10].
For pharmaceutical owners, Turner & Townsend’s digital tools provide a critical edge. Their digital benchmarking and real-time performance tracking systems help identify and address schedule and cost deviations early. These tools enhance project predictability and safety, making them a trusted partner for navigating the complexities of life sciences construction.
Linesight is a construction consultancy that focuses on delivering facilities for the life sciences and pharmaceutical industries. They specialize in environments like cGMP manufacturing plants and ATMP facilities, where precision and strict compliance are non-negotiable. Their approach integrates ESG principles with modular solutions to meet the unique demands of these sectors.
Their services include cost management, schedule management, project controls, and strategic contracting. Nigel Barnes, Head of Life Science at Linesight, highlights a growing trend:
"While cost or schedule tend to be the primary drivers for life sciences clients coming to Linesight for consultancy services, carbon is rapidly catching up." [11]
This shift reflects a broader industry focus on balancing financial considerations with environmental responsibility. Linesight helps pharmaceutical companies weigh the pros and cons of retrofitting existing facilities versus constructing new ones. This is especially relevant now, as refurbishment projects in the construction market outpaced new builds by a factor of two in Q1 2024 [11]. They also design flexible shell and core facilities that can adapt to evolving manufacturing needs, reducing the need for carbon-heavy demolitions.
To improve project timelines, Linesight employs modular manufacturing strategies like J.POD technology. Barnes underscores the benefits:
"Using modular units brings down project timelines and reduces emissions from onsite transport." [11]
These modular solutions not only accelerate timelines but also lower transport-related emissions - an edge in fast-paced markets such as Boston and San Diego, where speed-to-market can influence regulatory approvals and patient access to medicines. Additionally, Linesight audits materials, equipment suppliers, and supply chain logistics to address Scope 3 emissions. This capability is becoming increasingly important as both investors and regulators demand greater transparency in emissions reporting.
CRB is a fully integrated firm specializing in architecture, engineering, construction, and consulting, tailored specifically for the life sciences and pharmaceutical sectors. What sets CRB apart is its commitment to embedding compliance into facility design from the very beginning. As they emphasize: "Protecting patients is the top priority, so regulatory compliance isn't just a box to check." [6]
Their standout delivery method is ONEsolution™, a proprietary integrated project delivery approach. This method brings together designers, builders, trade partners, and owners to function as a unified team. By doing so, it tackles one of the biggest challenges in traditional construction: fragmented handoffs, which are responsible for nearly 80% of projects exceeding budgets or deadlines [12]. Andy Reitter, PE, ONEsolution Director at CRB, explains:
"ONEsolution defies the old project management adage of 'quality, cost and schedule – pick two.' Instead, ONEsolution aligns stakeholders on those targets from the very beginning." [12]
This collaborative approach has been key to CRB’s success in delivering mission-critical projects on time and within budget.
CRB's ability to deliver under tight deadlines is evident in their work with Catalent (formerly Acorda Therapeutics). They designed and constructed a 75,000-square-foot bioservice facility in just 15 months to support over 40 clinical programs. Chris Holmes, VP of Facilities & Engineering at Catalent, praised the achievement:
"With CRB, we achieved the impossible. In just 15 months, they helped us design and build a 75,000‑square‑foot state‑of‑the‑art bioservice facility... They conquered every challenge with innovation and skill." [14]
CRB's Operational Readiness team also plays a crucial role, focusing on quality systems, maintenance protocols, supply chain logistics, and regulatory compliance - all while compressing project timelines without sacrificing quality [13]. Their advanced therapy clients include National Resilience, Inc., Umoja Biopharma, and CARsgen Therapeutics [6] [15], showcasing their expertise in areas like cell and gene therapy, RNA therapies, aseptic processing, and cGMP manufacturing environments.
DPS Group is a full-service EPCMV firm with 45 years of process engineering experience and a team of 1,900 professionals across 14 global offices. One of their key U.S. hubs is in Framingham, MA, where they focus on the life sciences construction market [17]. Their expertise spans biotechnology, pharmaceuticals, and cutting-edge therapeutics, including mRNA, cell and gene therapy, and viral vectors.
The company provides a comprehensive range of services, from feasibility studies and architectural design to procurement, construction management, and CQV (commissioning, qualification, and validation). This one-stop-shop model reduces coordination challenges for project owners, ensuring smoother execution from concept to completion [17].
DPS employs Lean construction principles and adapts delivery models - such as design-build, EPCM, and Integrated Project Delivery - to match each project's specific pace and complexity. Their approach helps ensure cGMP projects are delivered on schedule and within budget [16]. As Jim Grunwald, Senior Vice President of U.S. Business Development at DPS Group, explains:
"The design of manufacturing facilities for the production of novel therapeutics involves... complex elements that require a project team to move quickly and effectively to de-risk the investment and meet market demand." [18]
This focus on agility and risk reduction enables DPS to handle the complexities of therapeutic facility projects efficiently.
Their track record in the Boston area is particularly noteworthy. Between 2017 and 2019, DPS, along with its design affiliate TRIA, delivered a 209,000-square-foot mRNA clinical manufacturing facility for Moderna in Norwood, MA. This project was fast-tracked to completion in just two years and designed for LEED certification. The facility brought together operations for nearly 200 employees and supported Phase 1 and Phase 2 clinical development programs [18]. Another standout project was a 27,000-square-foot cell therapy facility for Mustang Bio in Worcester, MA. DPS converted existing lab space into three cGMP ISO7 clinical production areas while leaving room for future CAR T and gene therapy expansion [18].
SSOE Group brings 30 years of expertise in designing pharmaceutical research facilities, laboratories, and cleanrooms [19]. Their client list includes industry leaders like Abbott Laboratories, Bristol Myers Squibb, Johnson & Johnson, Merck, Novartis, and Pfizer. With the acquisition of Integrated Engineering Services (IES), SSOE effectively doubled its capacity in the pharmaceutical sector, extending its services to high-demand markets such as San Diego [19].
The company emphasizes early-stage integration to streamline construction management and avoid unexpected challenges. By involving their construction management team from Day 1, SSOE ensures accurate estimates and schedules well before potential issues arise [20][21]. They also use an in-house tool to identify and address staffing gaps early in the process - an essential step for managing complex, highly regulated projects [21].
One standout project was for Cipla in Fall River, MA, where SSOE delivered a state-of-the-art inhalant medication manufacturing facility. This included a 6,143-square-foot addition, a 12,631-square-foot renovation, and a 2,430-square-foot mezzanine. The project replaced an outdated filling line with two new ISO 8 cGMP cleanroom manufacturing suites and a high-capacity filling line. Additionally, the facility underwent a complete utility overhaul, including new chiller systems, air handling units, and a dedicated propellant tank farm [22].
Another notable project was for HCW Biologics, completed in March 2024. SSOE, in collaboration with design-build partner BE&K, transformed 40,000 square feet of office and warehouse space into laboratories and cGMP production suites. The project included a 5,000-square-foot cleanroom with ISO 7 production labs and an ISO 6 sterile filling suite. SSOE also assisted the client in developing manufacturing procedures and establishing a QA/QC process, showcasing their expertise in aligning strategies with project-specific needs [20].
"SSOE's biggest strength is their flexibility. They were able to work with us in a changing business environment. We had some changes on our project and they were able to work with us to help us recover." - Senior Project Manager, Pharmaceutical Client [19]
SSOE's services cover a wide range of needs, including cGMP facility design, process engineering, CQV lifecycle services (IQ/OQ/PQ), digital twin technology, and advanced AI-driven tools [19][20]. Their ability to provide end-to-end solutions highlights their adaptability and expertise in navigating regulated environments.
When it comes to executing complex construction projects, having the right talent is just as critical as expert consulting. While construction consultants focus on ensuring project compliance and integrity, iRecruit.co steps in to supply the specialized professionals needed to bring these projects to life. Founded by Dallas Bond and Tanya Runholt, this recruitment firm zeroes in on talent for mission-critical facilities like cGMP manufacturing plants, R&D labs, cleanrooms, fill-finish facilities, and gene and cell therapy sites.
The life sciences and pharmaceutical industries face a significant talent gap. More than 80% of contractors struggle to fill both salaried and craft roles, especially those requiring experience with FDA-regulated projects. Generic job postings often fail to attract these highly skilled professionals. iRecruit.co addresses this challenge by using proactive headhunting strategies, a proprietary project tracker that monitors over 100 active life sciences construction projects and $120 billion in disclosed capital, and a referral network tailored to the industry [24].
The firm recruits talent across the entire project lifecycle. This includes roles like Owner's Representatives, Program Directors, CQV Engineers, Validation Leads, MEP Coordinators, and Commissioning Agents (BCxP). They also specialize in filling niche positions such as cleanroom specialists, cGMP Quality Managers, and Primavera P6 schedulers - all with experience in regulated facilities [24][26]. Every candidate undergoes rigorous screening to ensure they have direct experience with FDA or EMA-audited environments, aligning perfectly with the unique demands of these projects.
iRecruit.co’s hiring process is both fast and thorough. After an initial discovery call to clarify the facility type, delivery model, and schedule, the firm typically provides a shortlist of pre-screened, interview-ready candidates within 7 to 14 days. Senior placements are often finalized within 45 to 75 days. To add extra assurance, every plan includes a 90-day search credit - if a hire doesn’t meet performance expectations, a replacement search is initiated at no additional cost [23]. This approach ensures speed without compromising on quality, meeting the high stakes of life sciences and pharmaceutical construction projects.
The firm offers flexible engagement models to suit different project scales. For a single high-priority hire, clients can choose a contingency model, which charges 25% of the first-year salary with no monthly fee. For ongoing hiring needs tied to multi-year capital programs, the Embedded Recruiting model provides a dedicated recruiter who integrates into the client’s workflow on a monthly retainer [23][25]. With a 90% client retention rate and over 200 completed projects for more than 70 clients, iRecruit.co has proven its expertise in this highly specialized field [23][25].
Not every consultant is the right fit for every project. For example, a firm specializing in a sprawling 175,000 sq. ft. greenfield biomanufacturing campus might not be the best choice for a conversion project in the Midwest. From the outset, it’s critical to align the consultant and talent strategy with the specific project type. Doing so helps avoid delays and cost overruns - an essential thread throughout this discussion.
Here’s a breakdown of how project types align with consultant expertise, delivery models, and key factors in the U.S.:
| Project Type | Consultant Strength | Delivery Model | Key U.S. Factor |
|---|---|---|---|
| Greenfield Biomanufacturing | Site selection, master planning, large-scale utilities | EPCM / EPC | Regional capital budgets & land availability |
| Brownfield Retrofit | Equipment integration, HVAC/mechanical, structural upgrades | Design-Build | Local labor availability & existing zoning |
| Advanced Therapy (CGT/mRNA) | Modular cleanrooms, Grade B/A environments, flexible suites | Design-Assist / Modular | Proximity to R&D hubs (e.g., Boston, NJ) |
| R&D / Lab Fit-out | Specialized MEP, BSL-1/2/3 standards, VDC/BIM | CM at Risk | Talent density in life science clusters |
For greenfield biomanufacturing, consultants with expertise in modular replication can significantly speed up timelines for large-scale projects. A case in point: Jacobs used modular replication to deliver North America's largest cell culture site, cutting both costs and project duration [3]. On the other hand, brownfield retrofits demand a different approach. These projects benefit from firms that can address complex system integrations early in the process. For instance, Consigli's "construction-led design" integrates construction and CQV (commissioning, qualification, and validation) from the very start, minimizing the risk of late-stage redesigns [1].
Advanced therapy facilities, including those for cell, gene, and mRNA therapies, bring their own set of challenges. Speed-to-market is often a top priority, requiring consultants with experience in Grade A/B cleanrooms, isolator technology, and adaptable multi-suite layouts. Beyond technical expertise, the availability of regional talent can be a decisive factor. Being close to life science hubs like Boston or New Jersey can make it easier to secure specialists such as CQV engineers, cleanroom experts, and validation leads.
"Fast-tracked projects can only succeed when design, construction, commissioning, and validation are coupled with a smooth process for approvals involving regulatory bodies such as the FDA, EU, EPA, and OSHA." - IPS [9]
But it’s not just about the design and construction phases. Aligning talent strategies with the chosen delivery model is equally important. While consultants lay the groundwork for the facility, engaging the right professionals - like Owner's Representatives, MEP Coordinators, and Commissioning Agents - at the right time is critical to staying on schedule. Owners managing aggressive capital programs need to understand how delivery models like Design-Build, EPCM, or CM at Risk influence hiring timelines. By syncing your recruiting strategy with the delivery model, you can bring in the right expertise at the right phase, avoiding last-minute scrambles. This alignment strengthens the connection between project execution and talent acquisition, ensuring smooth, mission-critical delivery.
Life sciences and pharmaceutical projects come with unique challenges: tighter design requirements, stricter regulations, and higher stakes. Mistakes in this field don’t just cause headaches - they can lead to budget blowouts, missed schedules, or even validation failures. On average, large capital projects in this sector exceed budgets and timelines by 30% to 45% [27], and nearly 8 out of 10 projects face risks due to delays in detailed design [5]. These numbers highlight one thing: choosing the right specialist is not just important - it’s essential.
Firms like Turner & Townsend, Linesight, CRB, DPS Group, and SSOE Group each offer distinct expertise. The best fit for your project depends on factors like the type of project, the delivery model, and your stage in the capital program lifecycle. Whether it’s a greenfield biomanufacturing campus, a brownfield retrofit, or an advanced therapy fit-out, aligning with the right partner can make or break your project.
One universal truth applies to all project types: addressing issues early is the most effective way to control costs. Tackling potential problems before they escalate is what separates successful projects from those that spiral into costly recoveries.
But it’s not just about picking the right consultant. The human element of project delivery plays an equally critical role. Bringing in the right talent - whether it’s an Owner’s Representative, a CQV engineer, or a commissioning lead - at the right phase can mean the difference between a smooth startup and a costly delay. As iRecruit.co puts it, "The success of a project relies on construction leaders who understand that the building is part of the product." [24] In the life sciences and pharma industries, this mindset isn’t optional - it’s essential. Success lies in pairing expert consultants with a well-thought-out talent strategy, ensuring every phase from groundbreaking to validation runs seamlessly.
Including your Commissioning, Qualification, and Validation (CQV) team right from the beginning of your project is a smart move. By involving CQV experts during the planning and design phases, you can bake compliance protocols into the process early. This proactive approach helps you sidestep expensive rework, keeps delays to a minimum, and ensures your facility meets regulatory standards from day one.
Choosing the right delivery method comes down to what your project needs in terms of control, risk management, and collaboration. Here’s a quick breakdown of three popular methods:
Each method has its strengths, so it’s all about matching the approach to your project’s unique requirements.
To set up a successful cGMP facility, it's crucial to bring key team members on board early in the pre-design phase. Start by hiring process engineers, automation specialists, and commissioning, qualification, and validation (CQV) leads. Their expertise will lay the groundwork for the technical and operational aspects of the project.
Additionally, involve quality assurance (QA) and regulatory experts from the beginning. Their input helps identify and address compliance risks before they become costly issues. Lastly, bring in owner-side advisors to oversee schedules and ensure that both design and construction teams stay aligned with the project's goals. This proactive approach can save time, reduce risks, and keep everything on track.
